Tocil Jun 2026

Located right next to the residences, this reserve is a significant local green space managed by the Warwickshire Wildlife Trust Landscape:

IL-6 is a key driver of inflammation. High levels are associated with autoimmune disease progression, bone damage, and the "cytokine storm" seen in severe infections.

In an age of "disposable" products, the concept of the tocil represents sustainability and respect for craftsmanship. Sharpening a tool rather than replacing it is an act of conservation. It requires patience, a steady hand, and an understanding of geometry.

It is used to treat polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (SJIA) in children. 3. Giant Cell Arteritis (GCA) and Vasculitis Located right next to the residences, this reserve

| Indication | Approved Use / Status | Key Highlights | | :--- | :--- | :--- | | | Fully Approved (FDA, EMA) | Well-established; shown to be more effective than prednisone in reducing disease activity over 12 months. | | Systemic & Polyarticular JIA | Fully Approved (FDA, EMA) | Improves symptoms in children with severe arthritis unresponsive to other therapies. | | Giant Cell Arteritis (GCA) | Fully Approved (FDA, EMA) | Highly effective, allows significant reduction or cessation of glucocorticoid (steroid) use. | | Cytokine Release Syndrome (CRS) | Fully Approved (FDA) | First-line treatment for severe cases triggered by CAR-T cell therapy or immunotherapies. | | COVID-19 | Fully Approved (FDA) | Reduces mortality in hospitalized patients receiving oxygen/ventilation when combined with steroids. | | Systemic Sclerosis-ILD | Approved (FDA) | Slows the decline in lung function for patients with this autoimmune lung disease (SSc-ILD). | | Castleman's Disease | Approved (Japan) | Highly effective in managing systemic symptoms and improving lab values in multicentric Castleman’s disease (MCD). | | Prophylaxis (CRS prevention) | Investigational / Emerging | Promising evidence that pre-emptive dosing can prevent severe CRS following CAR-T therapy without compromising anti-tumor efficacy. |

Located at the University of Warwick, Tocil consists of popular student residences, known for their social atmosphere and close proximity to the Sports and Wellness Hub. Adjacent to the student housing lies Tocil Wood and Nature Reserve, a designated area of ancient woodland featuring diverse wildlife and the notable Tocil Lake. For more details, visit University of Warwick Tocil - University of Warwick

The immune system produces a signaling protein called , which can trigger inflammation. In certain diseases, the body produces too much IL-6, leading to chronic inflammation, tissue damage, and pain. Tocilizumab works by binding to both soluble and membrane-bound IL-6 receptors, blocking the IL-6 signal. This reduces the inflammatory response. Sharpening a tool rather than replacing it is

It is given either as an (usually every 4 weeks) or a subcutaneous injection (weekly or every other week), depending on the condition.

Approved for systemic juvenile idiopathic arthritis (SJIA) in children two years of age and older.

It is used in hospitalized patients experiencing rapid deterioration due to a severe immune response (cytokine storm), lowering the risk of mortality. lowering the risk of mortality.

TOCIL is your comprehensive guide to exploring and learning about the great outdoors. By following this guide, you'll gain a deeper understanding of outdoor activities, environmental awareness, and innovative learning techniques. Get ready to embark on an exciting journey of discovery and growth!

The main concern with IL-6 inhibition is a heightened susceptibility to infections, as the immune system is significantly dampened.